Six-Month Intravascular Ultrasound Follow-up of Coronary Bifurcation Lesions Treated With Rapamycin-Eluting Stents: Technical Considerations

Ormiston, 1999, Stent deformation following simulated side-branch dilatation comparison of five stent designs, Catheter Cardiovasc Interv., 47, 258, 10.1002/(SICI)1522-726X(199906)47:2<258::AID-CCD27>3.0.CO;2-C Lefévre, 2000, Stenting of bifurcation lesions: classification, treatments, and results, Catheter Cardiovasc Interv., 49, 274, 10.1002/(SICI)1522-726X(200003)49:3<274::AID-CCD11>3.0.CO;2-N Ormiston, 2004, Drug-eluting stents for coronary bifurcations: Insights into the crush technique, Catheter Cardiovasc Interv., 63, 332, 10.1002/ccd.20120 Pan, 2002, A Stepwise strategy for the stent treatment of bifurcated coronary lesions, Catheter Cardiovasc Interv., 55, 50, 10.1002/ccd.10057 Pan, 2004, Rapamycin-eluting stents for the treatment of bifurcated coronary lesions: A randomized comparison of a simple versus complex strategy, Am Heart J., 148, 857, 10.1016/j.ahj.2004.05.029 Suárez de Lezo, 2004, Rapamycin-eluting stents for the treatment of unprotected left main coronary disease, Am Heart J., 148, 481, 10.1016/j.ahj.2004.03.011 Degertekin, 2002, Persistent inhibition of neointimal hyperplasia sfter sirolimuseluting stent implantation. Long-term (up to 2 years) clinical angiographic, and intravascular ultrasound follow-up, Circulation, 106, 1610, 10.1161/01.CIR.0000034447.02535.D5 Sousa, 2003, Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries, Circulation, 107, 381, 10.1161/01.CIR.0000051720.59095.6D Degertekin, 2004, Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions, Eur Heart J., 25, 32, 10.1016/j.ehj.2003.10.012 Serruys, 2004, Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial, Circulation, 109, 627, 10.1161/01.CIR.0000112566.87022.32 López-Palop, 2004, Comparación de parámetros de expansión de stents implantados con técnica convencional o directa. Estudio aleatorizado con ultrasonidos intracoronarios, Rev Esp Cardiol., 57, 403, 10.1157/13061118 Fujii, 2004, Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for instent reestenosis, Circulation, 109, 1085, 10.1161/01.CIR.0000121327.67756.19 Colombo, 2004, Randomized study to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions, Circulation, 109, 1244, 10.1161/01.CIR.0000118474.71662.E3 Louvard, 2004, Percutaneous coronary intervention for bifurcation coronary disease, Heart, 90, 713, 10.1136/hrt.2002.007682 Brueck, 2002, Sequential vs. kissing balloon angioplasty for stenting of bifurcation coronary lesions, Catheter Cardiovasc Interv., 55, 461, 10.1002/ccd.10100 Hoye, 2004, Clinical and angiographic outcomes following crush bifurcation stenting with drug-eluting stents: low target lesion revascularization rates but high rate of side-branch restenosis in the absence of kissing balloon after dilatation (abstract), Circulation, 110, 757 Moussa, 2004, A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using The “Crush Technique” [abstract], Circulation, 110, 649 Sawhney, 2004, Treatment of bifurcation lesions with sirolimus eluting stents using the “Crush” and “V” techniques. procedural “Crush” and “V” techniques. Procedural and clinical outcomes [abstract], Circulation, 110, 649 Albiero, 2000, Edge restenosis after implantation of high activity 32P radioactive beta-emitting stents, Circulation, 101, 2454, 10.1161/01.CIR.101.21.2454 Moses, 2003, Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery, N Engl J Med., 349, 1315, 10.1056/NEJMoa035071